clinical studies bpc 157 safety Frontiers bpc-157 human clinical trials evidence

, Zhang, C

Haloperidol-induced catalepsy models: Haloperidol, a D2/D3 receptor antagonist, produces catalepsy (rigidity, reduced locomotion) in rodents by blocking nigrostriatal dopamine transmission a pharmacological model of dopamine receptor blockade resembling antipsychotic-induced parkinsonism

BPC 157 also possesses inflammation-modulating properties, though its mechanisms appear to be different

[PubMed] [Google Scholar] 55

The researchers assessed the hepatic capacity for synthesizing urea-N (CUNS), which is a potential indicator of nitrogen metabolism in the liver

Practical comparison Many people find their preferred site after trying all three over several weeks